Serum IL-6 and IL-8 levels in schizophrenia and changes with antipsychotic treatment;Şizofreni hastalarinda serum IL-6 ve IL-8 düzeylerinin antipsikotik tedaviyle deǧişimi

Klinik Psikofarmakoloji Bulteni

Volumn 17, Issue 2, 2007, Pages 55-61

  Türkoǧlu, Ali ^a   Şengül, Cem ^b   Okay, Tuncer ^c   Dilbaz, Nesrin ^c  

^a Çankiri Devlet Hastanesi ^*  (Turkey)

^b PAMUKKALE UNIVERSITY   (Turkey)

^c ANKARA NUMUNE HOSPITAL   (Turkey)

Author keywords

Antipsychotic treatment; Cytokines; IL 6; IL 8; Schizophrenia

Indexed keywords

BENZODIAZEPINE; CLOZAPINE; HALOPERIDOL; INTERLEUKIN 6; INTERLEUKIN 8; NEUROLEPTIC AGENT; RISPERIDONE;

ARTICLE; BLOOD SAMPLING; CLINICAL ARTICLE; COMPUTER PROGRAM; CONTROLLED STUDY; FEMALE; HUMAN; MALE; SCHIZOPHRENIA; STATISTICAL SIGNIFICANCE;

EID: 34347355501     PISSN: 10177833     EISSN: 13029657     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. McGuffin P, Asherson P, Owen M. The strength of the genetic effect. Is there room for any environmental influence in the etiology of schizophrenia? Br J Psychiatry 1994;164:593-599
2. Kronfol Z, Remick DG. Cytokines and brain: Implications for clinical psychiatry. Am J Psychiatry 2000;157:683-394
3. De-Lisi LE, Wyatt RJ, Abnormal immune regulation in schizophrenic patients. Psychopharmacol Bull 1982;18 :158-163
4. McAllister CG, Rappaport MH, Pickar D, Podruchny TA, Christison G, Alphs LD, Paul SM. Increased numbers of CD5 B lymphocytes in schizophrenic patients. Arch Gen Psychiatry 1989;46:890-894
5. Müller N, Ackenheil M, Hofschuster E, Eckstein R, Mempel V. Cellular immunity in schizophrenic patients before and during neuroleptic treatment. Psychiatry Res 1991;37:147-160
6. Hornberg M, Arolt V, Wilke I Kruse A, Kirchner H. Production of interferons and lyphokines in leukocyte cultures of patients with schizophrenia. Schizophr Res 1995;15:237-242
7. Licinio J, Seibyl JP, Altemus M, Charney DS, Kristal JH. Elevated CSF levels of interleukin-2 in neuroleptic-free schizophrenia patients. Am J Psychiatry 1993;150:1408-1410
8. Cazzullo CL, Scarone S, Grassi B, Vismara C, Trabattoni D, Clerici M. Cytokine production in chronic schizophrenic patients, with or without paranoid behavior. Prog NeuroPsychopharmacol Biol Psychiatry 1998;22:947-957
9. Zalcman S, Murray L, Dyck DG Greenberg AH, Nance DM. Interleukin-2 and 6 induce behavioral-activating effects in mice. Brain Res 1998;811:111-121
10. Spangelo B, Isakson PC, MacLeod RM. IL-6 stimulates anterior pituitary hormones release in vitro. Endocrinology 1989;125:575-577
11. Baggiolini M, Loetscher P, Moser B. Interleukin-8 and the chemokine family. Int J Immunopharmac 1995;17:103-108
12. Maes M, Bosmans E, Calabrese J, De Jongh R, Smith RS, Meltzer HY. Interleukin-2 and interleukin-6 in schizophrenia and mania: effects of neuroleptics and mood stabilizers. J Psychiatric Res 1995;29:141-152
13. Zhang XY, Zhou DF, Zhang PY Wu GY, Cao LY, Shen YC. Elevated interleukin-2, interleukin-6 and interleukin-8 serum levels in neuroleptic-free schizophrenia association with psychopathology. Schizophr Res 2002;57:247-258
14. Herken H, Erbaǧci A, Köylüoǧlu O, Yilmaz N, Tarakçioǧlu M. Serum IL-1_, sIL-2R, IL-6, IL-8 and TNF-α in schizophrenic patients relation with symptomatology and responsiveness to risperidone treatment. Mediators Inflamm 2001;10:109-115
15. Maes M, Bocchio Chiavetto L, Bignotti S Battisa T, Pioli R. Increased serum interleukin-8 and interleukin-10 in schizophrenic patients resistant to treatment with neuroleptics and stimulatory effects of clozapine on serum leukemia inhibitory factor receptor. Schizophrenia Res 2002;54:281-292
16. Müller N, Ackenheil M, Hofschuster E Eckstein R, Mempel V. Cellular immunity in schizophrenic patients before and during neuroleptic treatment. Psychiatry Res 1991; 37:147-160
17. Çorapçioǧlu A, Aydemir Ö, Yildiz M. DSM-IV Eksen I Bozukluklari (SCID-I) İçin Yapilandirilmiş Klinik Görüşme, 1999 Klinik Versiyon. Ankara, Hekimler Yayin Birliǧi
18. Erkoç Ş, Arkonaç O, Atakli C, Özmen E: Pozitif Semptomlari Deǧerlendirme Ölçeǧinin güvenilirliǧi ve geçerliliǧi. Düşünen Adam 1991; 4: 20-24
19. Erkoç Ş, Arkonaç O, Atakli C, Özmen E: Negatif Semptomlari Deǧerlendirme Ölçeǧinin güvenilirliǧi ve geçerliliǧi. Düşünen Adam 1991; 4:16-19
20. Ganguli R, McAllister CG. Alterations in interleukins and in T lymphocyte subsets in a subgroup of schizophrenics. Biol Psychiatry 1991; 29:109A
21. Ganguli R, Yang G, Shurin G, Chengappa KNR, Brar JS. Serum IL-6 concentration in schizophrenia: Elevation associated with duration of illness. Psychiatry Res 1994;51:1-10
22. Naudin J, Capo C, Giusano B, Mege JL, Azorin JM. A differential role for interleukin-6 and tumor necrosis factor-_ in schizophrenia. Schizophr Res 1997;26:227-233
23. Lin A, Kenis G, Bignotti S, Tura GJ, De Jong R Bosmans E, Pioli R, Altamura C, Scharpe S, Maes M. The inflammatory response system in treatment-resistant schizophrenia: increased serum interleukin-6 Schizophr Res 1998; 32: 9-15
24. Katila H, Appelberg B, Hurme M, Rimon R. Plasma levels of interleukin-1 beta and interleukin-6 in schizophrenia, other psychoses and affective disorders. Schizophr Res 1994;12:29-34
25. Baker I, Masserano J, Wyatt RJ. Serum cytokine concentrations in patients with schizophrenia. Schizophr Res 1996;20:199-203
26. Kim YK, Kim L, Lee MS. Relationship between interleukins, neurotransmitters and psychopathology in drug-free male schizophrenics. Schizophr Res 2000;44:165-175
27. Akiyama K. Serum levels of soluble IL-2 receptor alpha, IL-6 and IL-1 receptor antagonist in schizophrenia before and during neuroleptic administration. Schizophr Res 1999; 37:97-106
28. Maes M, Meltzer H, Bosmans E. Immune-inflammatory markers in schizophrenia: Comparison to normal controls and effects of clozapine. Acta Psychiatr Scand 1994;89:346-351
29. Kim DJ, Kim W, Yoon SJ, Go HJ, Choi BM, Jun TY, Kim YK. Effect of risperidon on serum cytokines. Int J Neurosci 2001;111:11-19
30. Frommberger UH, Bauer J, Haselbauer P Fraulin A, Riemann D, Berger M. Interleukin-6 plasma levels in depression and schizophrenia: comparison between the acute state and after remission. Eur Arch Psychiatry Clin Neurosci 1997;247:228-233
31. Kaminska T, Wysocka A, Marmurowska-Michalowska H, Dubas-Slemp H, Kandefer-Szerszen M. Investigation of serum cytokine levels and cytokine production in whole blood cultures of paranoid schizophrenic patients. Arch Immunol Ther Exp 2001; 49:439-445
32. Haack M, Hinze-Selch D, Fenzel T Kraus T, Kühn M, Pollmacher T. Plasma levels of cytokines and soluble cytokine receptors in psychiatric patients; effects of confounding factors an diagnosis. J Psychiatry Res 1999;33:407-418